CTD HOLDINGS IV TRAPPSOL CYCLO STUDY
The NNPDF Central Office has received notice that
CTD’s US trial parameters for the IV Trappsol Cyclo study in NPC
are now published at Clinical Trials.Gov.
CTD HOLDINGS PRESS RELEASE
CTD Holdings Announces MHRA Approval of Clinical Trial
Application for Treatment of NPC With Trappsol(R) Cyclo(TM)